CLARKE JOHN K
Insider CIK 1219015 · ALNY Director · MNTA Director · LIFE Director · VSTM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LIFE aTYR PHARMA INC | A Award deriv | 2024-05-22 | 2024-05-23 | 24,000 | — | $0 | 24,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2023-05-17 | 2023-05-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise deriv | 2023-04-26 | 2023-04-28 | 6,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise | 2023-04-26 | 2023-04-28 | 6,000 | — | $0 | 19,797 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2022-04-26 | 2022-04-28 | 6,000 | — | $0 | 6,000 | SEC↗ |
| LIFE aTYR PHARMA INC | S Sale | 2021-05-21 | 2021-05-25 | 2,500 | $4.34 | $10.8K | 108,083 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2021-04-28 | 2021-04-29 | 1,428 | — | $0 | 1,428 | SEC↗ |
| LIFE aTYR PHARMA INC | S Sale | 2020-09-02 | 2020-09-03 | 7,260 | $4.01 | $29.1K | 110,583 | SEC↗ |
| LIFE aTYR PHARMA INC | S Sale | 2020-08-28 | 2020-09-03 | 100 | $4.00 | $400 | 117,843 | SEC↗ |
| LIFE aTYR PHARMA INC | S Sale | 2020-08-27 | 2020-08-28 | 5,440 | $4.09 | $22.2K | 117,943 | SEC↗ |
| LIFE aTYR PHARMA INC | S Sale | 2020-08-26 | 2020-08-28 | 2,200 | $4.30 | $9.5K | 123,383 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2020-05-06 | 2020-05-08 | 1,428 | — | $0 | 1,428 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2019-05-08 | 2019-05-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-06-20 | 2018-06-22 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-05-31 | 2018-06-04 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-05-31 | 2018-06-04 | 10,042 | $100.33 | $1.01M | 11,091 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-05-31 | 2018-06-04 | 15,000 | $27.28 | $409.2K | 23,891 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-05-31 | 2018-06-04 | 2,758 | $99.38 | $274.1K | 21,133 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-05-31 | 2018-06-04 | 2,100 | $101.37 | $212.9K | 8,991 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-05-31 | 2018-06-04 | 100 | $101.97 | $10.2K | 8,891 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2018-05-15 | 2018-05-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-06-02 | 2017-06-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2017-05-09 | 2017-05-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-06-03 | 2016-06-07 | 11,250 | — | $0 | 11,250 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-05-24 | 2016-05-26 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-01-27 | 2016-01-29 | 19,428 | — | $0 | 19,428 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2015-07-08 | 2015-07-10 | 6,286 | — | $0 | 6,286 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2015-06-10 | 2015-06-11 | 17,750 | — | $0 | 176,350 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-06-01 | 2015-06-03 | 11,250 | — | $0 | 11,250 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2015-05-12 | 2015-05-14 | 38,400 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 4,320,173 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 2,127,660 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 1,536,787 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 2,400,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 3,600,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 893,655 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2015-05-12 | 2015-05-14 | 38,400 | $19.96 | $766.5K | 69,123 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2015-05-12 | 2015-05-14 | 38,400 | $10.44 | $400.9K | 107,523 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 1,758,158 | — | $0 | 1,758,158 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 92,306 | — | $0 | 104,878 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2014-06-12 | 2014-06-13 | 17,750 | — | $0 | 197,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-06-05 | 2014-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-05-21 | 2014-05-23 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-05-21 | 2014-05-23 | 10,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-05-21 | 2014-05-23 | 10,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-05-21 | 2014-05-23 | 6,908 | $55.47 | $383.2K | 2,800 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-05-21 | 2014-05-23 | 2,500 | $54.21 | $135.5K | 9,708 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-05-21 | 2014-05-23 | 22,792 | $52.95 | $1.21M | 12,208 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-05-21 | 2014-05-23 | 15,000 | $15.91 | $238.7K | 35,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-05-21 | 2014-05-23 | 10,000 | $7.08 | $70.8K | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-05-21 | 2014-05-23 | 2,800 | $56.19 | $157.3K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-05-21 | 2014-05-23 | 10,000 | $14.74 | $147.4K | 20,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-06-12 | 2013-06-13 | 23,171 | $9.60 | $222.4K | 2,329,121 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2013-06-11 | 2013-06-13 | 17,750 | — | $0 | 179,250 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-06-11 | 2013-06-12 | 25,000 | $9.22 | $230.5K | 2,305,950 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2013-06-04 | 2013-06-06 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-05-13 | 2013-05-15 | 25,000 | $9.74 | $243.5K | 2,280,950 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-05-01 | 2013-05-03 | 10,000 | $9.66 | $96.6K | 2,255,950 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-04-17 | 2013-04-19 | 5,631 | $9.50 | $53.5K | 2,245,950 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2012-12-18 | 2012-12-20 | 6,193 | $7.87 | $48.7K | 2,240,319 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2012-06-21 | 2012-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2012-06-13 | 2012-06-15 | 17,750 | — | $0 | 161,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2012-03-06 | 2012-03-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 4,000,000 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 444,444 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 2,500,000 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion | 2012-02-01 | 2012-02-03 | 714,285 | — | $0 | 1,857,142 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion | 2012-02-01 | 2012-02-03 | 1,142,857 | — | $0 | 1,142,857 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion | 2012-02-01 | 2012-02-03 | 126,984 | — | $0 | 1,984,126 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2012-02-01 | 2012-02-03 | 250,000 | $10.00 | $2.50M | 2,234,126 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | G Gift | 2010-12-06 | 2012-04-24 | 8,000 | — | $0 | 20,823 | SEC↗ |